Clarification of Reporting of Potential Conflicts of Interest in 2 Articles

Clarification of Reporting of Potential Conflicts of Interest in 2 Articles Letters Author Affiliation: Heller School for Social Policy and Management, Brandeis Error in Text: The Editorial titled “Psychological Consequences of Admission to University, Waltham, Massachusetts. the ICU: Helping Patients and Families” published in the July 16, 2019, issue ofJAMA had typographical errors in the text, including that the P value after the descrip- Corresponding Author: Andrew Kolodny, MD, Heller School for Social Policy tion of the higher risk of mortality in the intensive care unit among patients in the and Management, Brandeis University, 415 South St, Waltham, MA 02453 intervention group than in the control group was P > .01 rather than P < .01. This (akolodny@brandeis.edu). article has been corrected online. Published Online: September 4, 2019. doi:10.1001/jama.2019.12743 1. Rose L, Muttalib F, Adhikari NKJ. Psychological consequences of admission to Conflict of Interest Disclosures: Dr Kolodny reports being the executive the ICU: helping patients and families. JAMA. 2019;322(3):213-215. doi:10.1001/ director of Physicians for Responsible Opioid Prescribing; serving as a medical jama.2019.9059 expert for states and counties that have filed suits against opioid manufacturers Misspelling in Author Surname: In the Letter to the Editor titled “Treat-to- and as an expert witness in malpractice cases involving opioid prescribing; and Target Strategies in Rheumatoid Arthritis,” published in the July 2, 2019, issue of being the former chief medical officer of Phoenix House, a nonprofit addiction JAMA, the surname of the first author was misspelled. The author’s correct full treatment agency. name is Annette van der Helm-van Mil. This article has been corrected online. 1. Kolodny A, Frieden TR. Ten steps the federal government should take now to 1. van der Hem-van Mil AHM, Huizinga TWJ, Bloem JL. Treat-to-target reverse the opioid addiction epidemic. JAMA. 2017;318(16):1537-1538. doi:10. strategies in rheumatoid arthritis. JAMA. 2019;322(1):83. doi:10.1001/jama. 1001/jama.2017.14567 2019.5848 2. Kolodny A, Frieden TR. Government actions to curb the opioid epidemic–reply. JAMA. 2018;319(15):1620-1621. doi:10.1001/jama.2018.0745 3. Clarification of reporting of potential conflicts of interest in 2 articles [published September 24, 2019]. JAMA. doi:10.1001/jama.2019.14523 Guidelines for Letters Letters discussing a recent JAMA article should be submitted within 4 CORRECTION weeks of the article's publication in print. Letters received after 4 weeks will rarely be considered. Letters should not exceed 400 words of text Clarification of Reporting of Potential Conflicts of Interest in 2 Articles: In the and 5 references and may have no more than 3 authors. Letters report- Viewpoint titled “Ten Steps the Federal Government Should Take Now to Reverse ing original research should not exceed 600 words of text and 6 refer- the Opioid Addiction Epidemic” published in the October 24/31, 2017, issue and in the Letter titled “Government Actions to Curb the Opioid Epidemic—Reply” pub- ences and may have no more than 7 authors. They may include up to 2 lished in the April 17, 2018, issue of JAMA, an author’s potential conflicts of inter- tables or figures but online supplementary material is not allowed. All est disclosure statement was incomplete. In the Viewpoint, the disclosure state- letters should include a word count. Letters must not duplicate other ma- ment should have read as follows: “Dr Kolodny reported that he is the executive terial published or submitted for publication. Letters not meeting these director of Physicians for Responsible Opioid Prescribing (PROP) and serves as an expert witness in malpractice cases involving opioid prescribing.” For the Letter, specifications are generally not considered. Letters being considered for the disclosure statement should have read: “Dr Kolodny reported being the ex- publication ordinarily will be sent to the authors of the JAMA article, who ecutive director of Physicians for Responsible Opioid Prescribing; serves as a medi- will be given the opportunity to reply. Letters will be published at the cal expert for states and counties that have filed suits against opioid manufactur- discretion of the editors and are subject to abridgement and editing. Fur- ers and as an expert witness in malpractice cases involving opioid prescribing; and ther instructions can be found at http://jamanetwork.com/journals/ beingtheformerchiefmedicalofficerofPhoenixHouse,anonprofitaddictiontreat- ment agency.” These articles have been corrected online and a letter of explana- jama/pages/instructions-for-authors. A signed statement for author- tion appears in this issue. ship criteria and responsibility, financial disclosure, copyright transfer, 1. Kolodny A, Frieden TR. Ten steps the federal government should take now to and acknowledgment are required before publication. Letters should be reverse the opioid addiction epidemic. JAMA. 2017;318(16):1537-1538. doi:10. submitted via the JAMA online submission and review system at https:// 1001/jama.2017.14567 manuscripts.jama.com. For technical assistance, please contact 2. Kolodny A, Frieden TR. Government actions to curb the opioid jama-letters@jamanetwork.org. epidemic—reply. JAMA. 2018;319(15):1620-1621. doi:10.1001/jama.2018.0745 3. Kolodny A. Clarification of reporting of potential conflicts of interest in JAMA articles [published September 24, 2019]. JAMA. doi:10.1001/jama.2019.12743 Section Editor: Jody W. Zylke, MD, Deputy Editor. jama.com (Reprinted) JAMA September 24, 2019 Volume 322, Number 12 1215 © 2019 American Medical Association. All rights reserved. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Clarification of Reporting of Potential Conflicts of Interest in 2 Articles

JAMA, Volume 322 (12) – Sep 24, 2019

Loading next page...
 
/lp/american-medical-association/clarification-of-reporting-of-potential-conflicts-of-interest-in-2-oLzJhOMqGM
Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2019.14523
Publisher site
See Article on Publisher Site

Abstract

Letters Author Affiliation: Heller School for Social Policy and Management, Brandeis Error in Text: The Editorial titled “Psychological Consequences of Admission to University, Waltham, Massachusetts. the ICU: Helping Patients and Families” published in the July 16, 2019, issue ofJAMA had typographical errors in the text, including that the P value after the descrip- Corresponding Author: Andrew Kolodny, MD, Heller School for Social Policy tion of the higher risk of mortality in the intensive care unit among patients in the and Management, Brandeis University, 415 South St, Waltham, MA 02453 intervention group than in the control group was P > .01 rather than P < .01. This (akolodny@brandeis.edu). article has been corrected online. Published Online: September 4, 2019. doi:10.1001/jama.2019.12743 1. Rose L, Muttalib F, Adhikari NKJ. Psychological consequences of admission to Conflict of Interest Disclosures: Dr Kolodny reports being the executive the ICU: helping patients and families. JAMA. 2019;322(3):213-215. doi:10.1001/ director of Physicians for Responsible Opioid Prescribing; serving as a medical jama.2019.9059 expert for states and counties that have filed suits against opioid manufacturers Misspelling in Author Surname: In the Letter to the Editor titled “Treat-to- and as an expert witness in malpractice cases involving opioid prescribing; and Target Strategies in Rheumatoid Arthritis,” published in the July 2, 2019, issue of being the former chief medical officer of Phoenix House, a nonprofit addiction JAMA, the surname of the first author was misspelled. The author’s correct full treatment agency. name is Annette van der Helm-van Mil. This article has been corrected online. 1. Kolodny A, Frieden TR. Ten steps the federal government should take now to 1. van der Hem-van Mil AHM, Huizinga TWJ, Bloem JL. Treat-to-target reverse the opioid addiction epidemic. JAMA. 2017;318(16):1537-1538. doi:10. strategies in rheumatoid arthritis. JAMA. 2019;322(1):83. doi:10.1001/jama. 1001/jama.2017.14567 2019.5848 2. Kolodny A, Frieden TR. Government actions to curb the opioid epidemic–reply. JAMA. 2018;319(15):1620-1621. doi:10.1001/jama.2018.0745 3. Clarification of reporting of potential conflicts of interest in 2 articles [published September 24, 2019]. JAMA. doi:10.1001/jama.2019.14523 Guidelines for Letters Letters discussing a recent JAMA article should be submitted within 4 CORRECTION weeks of the article's publication in print. Letters received after 4 weeks will rarely be considered. Letters should not exceed 400 words of text Clarification of Reporting of Potential Conflicts of Interest in 2 Articles: In the and 5 references and may have no more than 3 authors. Letters report- Viewpoint titled “Ten Steps the Federal Government Should Take Now to Reverse ing original research should not exceed 600 words of text and 6 refer- the Opioid Addiction Epidemic” published in the October 24/31, 2017, issue and in the Letter titled “Government Actions to Curb the Opioid Epidemic—Reply” pub- ences and may have no more than 7 authors. They may include up to 2 lished in the April 17, 2018, issue of JAMA, an author’s potential conflicts of inter- tables or figures but online supplementary material is not allowed. All est disclosure statement was incomplete. In the Viewpoint, the disclosure state- letters should include a word count. Letters must not duplicate other ma- ment should have read as follows: “Dr Kolodny reported that he is the executive terial published or submitted for publication. Letters not meeting these director of Physicians for Responsible Opioid Prescribing (PROP) and serves as an expert witness in malpractice cases involving opioid prescribing.” For the Letter, specifications are generally not considered. Letters being considered for the disclosure statement should have read: “Dr Kolodny reported being the ex- publication ordinarily will be sent to the authors of the JAMA article, who ecutive director of Physicians for Responsible Opioid Prescribing; serves as a medi- will be given the opportunity to reply. Letters will be published at the cal expert for states and counties that have filed suits against opioid manufactur- discretion of the editors and are subject to abridgement and editing. Fur- ers and as an expert witness in malpractice cases involving opioid prescribing; and ther instructions can be found at http://jamanetwork.com/journals/ beingtheformerchiefmedicalofficerofPhoenixHouse,anonprofitaddictiontreat- ment agency.” These articles have been corrected online and a letter of explana- jama/pages/instructions-for-authors. A signed statement for author- tion appears in this issue. ship criteria and responsibility, financial disclosure, copyright transfer, 1. Kolodny A, Frieden TR. Ten steps the federal government should take now to and acknowledgment are required before publication. Letters should be reverse the opioid addiction epidemic. JAMA. 2017;318(16):1537-1538. doi:10. submitted via the JAMA online submission and review system at https:// 1001/jama.2017.14567 manuscripts.jama.com. For technical assistance, please contact 2. Kolodny A, Frieden TR. Government actions to curb the opioid jama-letters@jamanetwork.org. epidemic—reply. JAMA. 2018;319(15):1620-1621. doi:10.1001/jama.2018.0745 3. Kolodny A. Clarification of reporting of potential conflicts of interest in JAMA articles [published September 24, 2019]. JAMA. doi:10.1001/jama.2019.12743 Section Editor: Jody W. Zylke, MD, Deputy Editor. jama.com (Reprinted) JAMA September 24, 2019 Volume 322, Number 12 1215 © 2019 American Medical Association. All rights reserved.

Journal

JAMAAmerican Medical Association

Published: Sep 24, 2019

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off